Research programme: pain therapeutics - Aerial BioPharmaAlternative Names: Prostatic acid phosphatase - Aerial BioPharma
Latest Information Update: 23 Jan 2014
At a glance
- Originator Aerial BioPharma
- Class Enzymes
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Pain
Most Recent Events
- 23 Jan 2014 Preclinical trials in Pain in USA (Parenteral)